| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 12/25/2013 | EP2675482A2 Carrier peptides for cell delivery |
| 12/25/2013 | EP2458379B1 Specific molecules clinging to a lure |
| 12/25/2013 | CN103476788A Immunogenic chikungunya virus peptides |
| 12/25/2013 | CN103467575A Preparation method of pasireotide |
| 12/25/2013 | CN103467574A Purification method of desmopressin acetate |
| 12/25/2013 | CN103467573A Carbetocin preparation method |
| 12/25/2013 | CN103467572A Antifreeze polypeptide prepared by utilizing alkaline protease to carry out enzymolysis on collagens from fish skins |
| 12/25/2013 | CN103467571A Livestock and poultry immune enhancer bursa fabricius polypeptide |
| 12/25/2013 | CN103467570A Transmembrane polypeptide with analgesic effect |
| 12/25/2013 | CN103467569A Short peptide for bacterium resisting, itching relieving, inflammation diminishing, swelling eliminating and scar removing, and its application |
| 12/25/2013 | CN103467568A Sepia esculenta protein antioxidant peptide, and preparation method and use thereof |
| 12/25/2013 | CN103463633A Targeting chimeric hepatitis B core antigen therapeutic vaccine and uses thereof |
| 12/25/2013 | CN103463621A NA+/K+-Atpase-specific peptide inhibitors/activators of Src and Src family kinases |
| 12/25/2013 | CN102633864B GPC3 antigen polypeptide, anti-GPC3 polyclonal antibody and application thereof |
| 12/25/2013 | CN102586374B Angiotensin-converting enzyme inhibitory peptide and preparation method thereof |
| 12/25/2013 | CN102372766B O-type foot-and-mouth disease multi-epitope vaccine |
| 12/25/2013 | CN102127149B Myocardial specificity homeobox part polypeptide and application thereof |
| 12/25/2013 | CN101787073B Methods and compositions for treatment of gastrointestinal disorders |
| 12/24/2013 | US8614291 Phosphorylated polymers and conjugates thereof |
| 12/24/2013 | US8614290 Cancer imaging and treatment |
| 12/24/2013 | US8614289 Processes for the manufacture of macrocyclic depsipeptides and new intermediates |
| 12/24/2013 | US8614193 Depsipeptides and their therapeutic use |
| 12/24/2013 | US8614176 Peptide vaccines for lung cancers expressing TTK, URLC10 or KOC1 polypeptides |
| 12/24/2013 | US8613931 Compounds for treating beta-amyloidoses |
| 12/24/2013 | US8613928 Immunizing composition and method for inducing an immune response against the β-secretase cleavage site of amyloid precursor protein |
| 12/24/2013 | DE102009055015B4 Hefe-Sekretionssystem auf Basis einer Signalsequenz aus der Hydrophobin 1-Gensequenz von Trichoderma reesei Yeast secretion system on the basis of a signal sequence of the hydrophobin 1 gene sequence of Trichoderma reesei |
| 12/24/2013 | CA2623898C New cyclic peptide compounds |
| 12/24/2013 | CA2609558C Identification of compounds modifying a cellular response |
| 12/24/2013 | CA2529307C Methods and compositions for the treatment of gastrointestinal disorders |
| 12/24/2013 | CA2520372C Stq-peptides |
| 12/19/2013 | WO2013188794A1 Novel microcin and uses thereof |
| 12/19/2013 | WO2013186934A1 Anti-pancreatic-cancer peptide |
| 12/19/2013 | WO2013186752A1 Monoclonal antibodies able to bind the viral hcv e2 protein preparation and use thereof |
| 12/19/2013 | WO2012122059A9 Hydrogen bond surrogate macrocycles as modulators of ras |
| 12/19/2013 | US20130338341 Peptides Having Antimicrobial Activity |
| 12/19/2013 | US20130338340 Peptides Having Antimicrobial Activity |
| 12/19/2013 | US20130338338 Alpha-conotoxin peptides |
| 12/19/2013 | US20130338085 Mucin hypersecretion inhibitors and methods of use |
| 12/19/2013 | US20130338081 Iap antagonists |
| 12/19/2013 | US20130338075 Methods and compositions for the treatment of axonal and neuronal degeneration |
| 12/19/2013 | US20130338063 Methods and Compositions for the Treatment of Gastrointestinal Disorders |
| 12/19/2013 | US20130338061 Salts and Polymorphs of Sulfamide NS3 Inhibitors |
| 12/19/2013 | US20130337028 Biomimetic peptides for bone augmentation |
| 12/19/2013 | US20130337002 Peptide scaffold design |
| 12/19/2013 | US20130336904 Novel anti-ageing peptides modulating survivin and compositions including same |
| 12/19/2013 | DE102012105193A1 Stimulation der zellulären Immunantwort gegen das Epstein-Barr-Virus (EBV) Stimulation of the cellular immune response against the Epstein-Barr virus (EBV) |
| 12/18/2013 | EP2674437A1 Novel antibacterial agents for the treatment of GRAM positive infections |
| 12/18/2013 | EP2673005A1 Materials and methods relating to cardiovascular imaging |
| 12/18/2013 | EP2673001A2 Nts-polyplex nanoparticles system for gene therapy of cancer |
| 12/18/2013 | EP2523967B1 Novel anti-ageing peptides modulating survivin and compositions including same |
| 12/18/2013 | CN103458931A Nts-polyplex nanoparticles system for gene therapy of cancer |
| 12/18/2013 | CN103450347A Polypeptide and gene vaccine used for treating alzheimer disease |
| 12/18/2013 | CN103450346A Liquid-phase synthesis method of eptifibatide |
| 12/18/2013 | CN103450345A Vip片段和应用方法 Vip fragments and application methods |
| 12/18/2013 | CN103450344A Tetrahydroisoquinolinyl-3-carboxylic acid modified LARGD heptapeptides, and synthesis, antithrombotic activity and application thereof |
| 12/18/2013 | CN103450343A Tetrahydroisoquinolinyl-3-carboxylic acid modified TARGD heptapeptides, and synthesis, antithrombotic activity and application thereof |
| 12/18/2013 | CN103450342A Tetrahydroisoquinolinyl-3-carboxylic acid modified PARGD heptapeptides, and synthesis, antithrombotic activity and application thereof |
| 12/18/2013 | CN103450341A Deuterohemin-His-Peptide (DhHP-6) derivatives, and preparation methods and uses thereof |
| 12/18/2013 | CN103450340A Heterocyclic carboxylic acid-modified anti-tumor oligopeptides and their synthesis, anti-tumor effects and application |
| 12/18/2013 | CN103450339A LRGD peptide-modified carbolino-hexahydropyrazine-1,4-diketones and their preparation method, antithrombotic effect and use |
| 12/18/2013 | CN103450338A Heterocyclic carboxylic acid-modified thymopentins and their preparation method, anti-tumor effect and use |
| 12/18/2013 | CN103450337A TRGD peptide-modified carbolino-hexahydropyrazine-1,4-diketones and their preparation method, antithrombotic effect and use |
| 12/18/2013 | CN103450336A KRGD peptide-modified carbolino-hexahydropyrazine-1,4-diketones and their preparation method, antithrombotic effect and use |
| 12/18/2013 | CN103030682B Enzyme-sensitive supramolecular hydrogel nano material, gelator and preparation method of gelator |
| 12/18/2013 | CN102757482B Polypeptide and application thereof |
| 12/18/2013 | CN102746380B Application of angiogenesis inhibitor polypeptide to preparation of medicine for treating tumor and rheumatoid arthritis |
| 12/18/2013 | CN102558346B Monoclonal antibody anti-phiX174 phage splitting protein E, hybridoma cell strain producing antibody and epitope thereof |
| 12/18/2013 | CN102532268B Oligopeptide with breast cancer resistant activity and application thereof |
| 12/18/2013 | CN102382176B Oral cavity cariogenic bacterium-resisting polypeptide Pm11 and preparation method thereof |
| 12/18/2013 | CN102286072B Staphylococcus aureus AgrC group induction system resistant auto-induced peptide (AIP) polypeptide derivatives and use thereof |
| 12/17/2013 | US8609610 Inhibitors of the trypsin-like site of the proteasome and methods of use thereof |
| 12/17/2013 | CA2492598C Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 12/12/2013 | WO2013184986A2 Methods and compositions for inhibiting angiogenesis |
| 12/12/2013 | WO2013184514A1 Site-specific labeling methods and molecules produced thereby |
| 12/12/2013 | WO2013183707A1 Screening method for peptide binding to target molecule in ph-dependent manner |
| 12/12/2013 | WO2013183048A1 Functionalized titanium binding peptides and implants coated with same |
| 12/12/2013 | WO2013182661A1 Peptides derived from viral proteins for use as immunogens and dosage reactants |
| 12/12/2013 | WO2013182650A1 Method and pharmaceutical composition for use in the treatment of cancer |
| 12/12/2013 | WO2013182240A1 Beta-hairpin peptidomimetics |
| 12/12/2013 | WO2013181947A1 Polypeptide specifically bonding rare earth nanoparticles and use thereof |
| 12/12/2013 | US20130331333 Par1 and par2 c-tail peptides and peptide mimetics |
| 12/12/2013 | US20130331322 Exendins and exendin agonist analogs to regulate gastrointestinal motility |
| 12/12/2013 | US20130330773 Macrocyclic compounds with a hybrid peptidic/non-peptidic backbone and methods for their preparation |
| 12/12/2013 | US20130330744 Nitrated cardiac troponin i as a biomarker of cardiac ischemia |
| 12/12/2013 | US20130330422 Methods for increasing insulin sensitivity and treating diabetes with a bioactive chromium binding peptide |
| 12/12/2013 | US20130330368 Eye drop composition for prevention and treatment of ophthalmic diseases containing fusion protein of fk506 binding protein |
| 12/12/2013 | CA2875733A1 Beta-hairpin peptidomimetics |
| 12/12/2013 | CA2874923A1 Peptides derived from viral proteins for use as immunogens and dosage reactants |
| 12/11/2013 | EP2671952A1 Method for preparing cyclic lipopeptide compound |
| 12/11/2013 | EP2671889A2 RF amide-related peptides and methods thereof |
| 12/11/2013 | EP2671597A1 Chimeric constructs between glioma-homing peptide and cell-penetrating peptides, gHoPe2 |
| 12/11/2013 | EP2671592A2 Vaccine |
| 12/11/2013 | EP2670766A1 Novel peptides involved in the scf c-kit signalling pathway and compositions comprising same |
| 12/11/2013 | CN103443119A Cyclosporine analogue molecules modified at amino acid 1 and 3 |
| 12/11/2013 | CN103443118A Novel peptide |
| 12/11/2013 | CN103443117A Aptamer-modified polymeric materials for the binding of therapeutic factors in a wound environment |
| 12/11/2013 | CN103435687A Method for purifying carbetocin |
| 12/11/2013 | CN103435686A Polypeptide Cbf-14 resisting infection of drug-resistant bacteria and application thereof |
| 12/11/2013 | CN103435685A Monoclonal antibody capable of resisting fibrinogen-like protein, and application thereof |
| 12/11/2013 | CN103435684A 18F-fluorine labeling pentapeptide complex and synthetic method thereof |